(Q37534611)

20 August 2017

1 reference

title

Pulmonary neuroendocrine/carcinoid tumors: a review article (English)

1 reference

20 August 2017

1 reference

Erin M Bertino

1

1 reference

20 August 2017

Patricia D Confer

2

1 reference

20 August 2017

Jorge E Colonna

3

1 reference

20 August 2017

Patrick Ross

4

1 reference

20 August 2017

Gregory A Otterson

5

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

20 August 2017

1 reference

20 August 2017

115

1 reference

20 August 2017

4434-4441

1 reference

20 August 2017

19

1 reference

Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization

20 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

An analysis of 8305 cases of carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.24498

1 reference

7 January 2021

Update in pulmonary carcinoid tumors: a review article

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Tumour biology and histopathology of neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

The new World Health Organization classification of lung tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

The 2004 World Health Organization classification of lung tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Evaluation of primary pulmonary carcinoid tumors using FDG PET

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Octreoscan in patients with bronchial carcinoid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

The surgical spectrum of pulmonary neuroendocrine neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Operative risk and prognostic factors of typical bronchial carcinoid tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Experience in treatment of metastatic pulmonary carcinoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Activity of sunitinib in patients with advanced neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Radiation therapy in the management of patients with malignant carcinoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Reproducibility of neuroendocrine lung tumor classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24498

7 January 2021

Identifiers

DOI

10.1002/CNCR.24498

1 reference

20 August 2017

1 reference